BOOTHBAY FUND MANAGEMENT, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$219,000
-33.0%
215,000
-9.2%
0.01%
-45.5%
Q2 2021$327,000
-3.8%
236,742
+18.4%
0.01%
-15.4%
Q1 2021$340,000
+353.3%
200,000
+827.0%
0.01%
+85.7%
Q1 2019$75,000
-40.9%
21,575
-60.8%
0.01%
-63.2%
Q4 2018$127,00055,0670.02%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders